Notice2025-00543
Foreign-Trade Zone (FTZ) 49, Notification of Proposed Production Activity; Merck, Sharp & Dohme LLC; (Pharmaceutical Products for Research and Development); Rahway, New Jersey
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 14, 2025
Issuing agencies
Commerce DepartmentForeign-Trade Zones Board
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 8 (Tuesday, January 14, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 8 (Tuesday, January 14, 2025)]
[Notices]
[Page 3173]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-00543]
[[Page 3173]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-2-2025]
Foreign-Trade Zone (FTZ) 49, Notification of Proposed Production
Activity; Merck, Sharp & Dohme LLC; (Pharmaceutical Products for
Research and Development); Rahway, New Jersey
Merck, Sharp & Dohme LLC submitted a notification of proposed
production activity to the FTZ Board (the Board) for its facility in
Rahway, New Jersey, within Subzone 49Y. The notification conforming to
the requirements of the Board's regulations (15 CFR 400.22) was
received on January 3, 2025.
Pursuant to 15 CFR 400.14(b), FTZ production activity would be
limited to the specific foreign-status material(s)/component(s) and
specific finished product(s) described in the submitted notification
(summarized below) and subsequently authorized by the Board. The
benefits that may stem from conducting production activity under FTZ
procedures are explained in the background section of the Board's
website--accessible via <a href="http://www.trade.gov/ftz">www.trade.gov/ftz</a>. The proposed finished
product(s) and material(s)/component(s) would be added to the
production authority that the Board previously approved for the
operation, as reflected on the Board's website.
The proposed finished products include MK-0616 macrocycle metabolic
disorders drug product, MK-6204 metabolic disorders drug product and
MK-5608 immunological disorder macrocyclic peptide drug product (duty-
free).
The proposed foreign-status materials/components include: MK-0616
macrocycle metabolic disorders active pharmaceutical ingredient; MK-
6204 metabolic disorders alkaloid active pharmaceutical ingredient; MK-
6204 metabolic disorders monoclonal antibody active pharmaceutical
ingredient; MK-5608 macrocyclic peptide immunological disorder active
pharmaceutical ingredient; sodium caprate; microcrystalline cellulose;
and, empty hydroxypropyl methylcellulose (HPMC) capsules (duty rate
ranges from duty-free to 6.5%). The request indicates that certain
materials/components are subject to duties under section 301 of the
Trade Act of 1974 (section 301), depending on the country of origin.
The applicable section 301 decisions require subject merchandise to be
admitted to FTZs in privileged foreign status (19 CFR 146.41).
Public comment is invited from interested parties. Submissions
shall be addressed to the Board's Executive Secretary and sent to:
<a href="/cdn-cgi/l/email-protection#a1c7d5dbe1d5d3c0c5c48fc6ced7"><span class="__cf_email__" data-cfemail="036577794377716267662d646c75">[email protected]</span></a>. The closing period for their receipt is February 24,
2025.
A copy of the notification will be available for public inspection
in the ``Online FTZ Information System'' section of the Board's
website.
For further information, contact Diane Finver at
<a href="/cdn-cgi/l/email-protection#76321f17181358301f1800130436020417121358111900"><span class="__cf_email__" data-cfemail="f1b598909f94dfb7989f879483b18583909594df969e87">[email protected]</span></a>.
Dated: January 7, 2025.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2025-00543 Filed 1-13-25; 8:45 am]
BILLING CODE 3510-DS-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on January 14, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.